Effect of intravenous vitamin C on chemotherapy adverse effects in nasopharyngeal cancer patients: A randomized double-blinded, placebo-controlled trial phase III.

Not Applicable

• Conditions: asopharyngeal cancer patients; Adverse effect, chemotherapy, nasopharyngeal cancer, intravenous vitamin C, side effect

• Registration Number: TCTR20190316003
• Lead Sponsor: Faculty of Medicine, Prince of Songkla University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-03-16
• Study Completion: 2020-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 86

Inclusion Criteria

Nasopharyngeal cancer patients who plan to treat with Concurrent Chemoradiation

Exclusion Criteria

- Glucose-6-phosphate Dehydrogenase (G-6-PD deficiency) patient
- Renal stone patient

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction of chemotherapy adverse effect 2 wk after chemotherapy Common Terminology Criteria for Adverse Events version 5.0

Secondary Outcome Measures

Name	Time	Method
Safety; Adverse events 0, 1.0, 2.0, 4.0, 6.0, 8.0, 12.0, 24.0, 48.0, 72.0 and 96.0 hours Safety monitoring